Annual revenue:
$4.07B+$234.75M(+6.12%)Summary
- As of today (May 20, 2025), JAZZ annual revenue is $4.07 billion, with the most recent change of +$234.75 million (+6.12%) on December 31, 2024.
- During the last 3 years, JAZZ annual revenue has risen by +$974.71 million (+31.50%).
- JAZZ annual revenue is now at all-time high.
Performance
JAZZ Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$897.84M-$190.33M(-17.49%)Summary
- As of today (May 20, 2025), JAZZ quarterly revenue is $897.84 million, with the most recent change of -$190.33 million (-17.49%) on March 1, 2025.
- Over the past year, JAZZ quarterly revenue has dropped by -$4.14 million (-0.46%).
- JAZZ quarterly revenue is now -17.49% below its all-time high of $1.09 billion, reached on December 31, 2024.
Performance
JAZZ Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$4.06B-$4.14M(-0.10%)Summary
- As of today (May 20, 2025), JAZZ TTM revenue is $4.06 billion, with the most recent change of -$4.14 million (-0.10%) on March 1, 2025.
- Over the past year, JAZZ TTM revenue has increased by +$221.43 million (+5.76%).
- JAZZ TTM revenue is now -0.10% below its all-time high of $4.07 billion, reached on December 31, 2024.
Performance
JAZZ TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
JAZZ Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.1% | -0.5% | +5.8% |
| 3 y3 years | +31.5% | +10.3% | +23.2% |
| 5 y5 years | +88.2% | +67.9% | +85.8% |
JAZZ Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +31.5% | -17.5% | +10.3% | -0.1% | +23.2% |
| 5 y | 5-year | at high | +88.2% | -17.5% | +67.9% | -0.1% | +85.8% |
| alltime | all time | at high | >+9999.0% | -17.5% | >+9999.0% | -0.1% | >+9999.0% |
JAZZ Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $897.84M(-17.5%) | $4.06B(-0.1%) |
| Dec 2024 | $4.07B(+6.1%) | $1.09B(+3.1%) | $4.07B(+1.9%) |
| Sep 2024 | - | $1.05B(+3.0%) | $3.99B(+2.1%) |
| Jun 2024 | - | $1.02B(+13.5%) | $3.91B(+1.7%) |
| Mar 2024 | - | $901.98M(-10.9%) | $3.84B(+0.2%) |
| Dec 2023 | $3.83B(+4.8%) | $1.01B(+4.1%) | $3.83B(+1.0%) |
| Sep 2023 | - | $972.14M(+1.5%) | $3.79B(+0.8%) |
| Jun 2023 | - | $957.32M(+7.2%) | $3.76B(+0.7%) |
| Mar 2023 | - | $892.81M(-8.2%) | $3.74B(+2.2%) |
| Dec 2022 | $3.66B(+18.3%) | $972.12M(+3.3%) | $3.66B(+2.1%) |
| Sep 2022 | - | $940.65M(+0.8%) | $3.58B(+2.9%) |
| Jun 2022 | - | $932.88M(+14.6%) | $3.48B(+5.5%) |
| Mar 2022 | - | $813.72M(-9.3%) | $3.30B(+6.7%) |
| Dec 2021 | $3.09B(+30.9%) | $896.73M(+7.0%) | $3.09B(+8.1%) |
| Sep 2021 | - | $838.12M(+11.5%) | $2.86B(+9.0%) |
| Jun 2021 | - | $751.81M(+23.7%) | $2.63B(+7.8%) |
| Mar 2021 | - | $607.58M(-8.7%) | $2.44B(+3.1%) |
| Dec 2020 | $2.36B(+9.3%) | $665.52M(+10.8%) | $2.36B(+3.7%) |
| Sep 2020 | - | $600.89M(+6.8%) | $2.28B(+2.9%) |
| Jun 2020 | - | $562.44M(+5.2%) | $2.22B(+1.3%) |
| Mar 2020 | - | $534.73M(-8.1%) | $2.19B(+1.2%) |
| Dec 2019 | $2.16B(+14.3%) | $581.74M(+8.2%) | $2.16B(+5.1%) |
| Sep 2019 | - | $537.70M(+0.7%) | $2.06B(+3.4%) |
| Jun 2019 | - | $534.13M(+5.1%) | $1.99B(+1.7%) |
| Mar 2019 | - | $508.19M(+6.7%) | $1.95B(+3.4%) |
| Dec 2018 | $1.89B(+16.8%) | $476.46M(+1.5%) | $1.89B(+2.2%) |
| Sep 2018 | - | $469.37M(-6.2%) | $1.85B(+3.2%) |
| Jun 2018 | - | $500.48M(+12.6%) | $1.79B(+6.3%) |
| Mar 2018 | - | $444.61M(+1.9%) | $1.69B(+4.2%) |
| Dec 2017 | $1.62B(+8.8%) | $436.40M(+6.0%) | $1.62B(+2.5%) |
| Sep 2017 | - | $411.86M(+4.4%) | $1.58B(+2.4%) |
| Jun 2017 | - | $394.39M(+4.9%) | $1.54B(+0.9%) |
| Mar 2017 | - | $376.05M(-5.2%) | $1.53B(+2.7%) |
| Dec 2016 | $1.49B(+12.3%) | $396.62M(+6.0%) | $1.49B(+3.9%) |
| Sep 2016 | - | $374.18M(-1.8%) | $1.43B(+2.4%) |
| Jun 2016 | - | $381.16M(+13.4%) | $1.40B(+3.5%) |
| Mar 2016 | - | $336.01M(-1.4%) | $1.35B(+2.0%) |
| Dec 2015 | $1.32B | $340.88M(+0.0%) | $1.32B(+1.0%) |
| Sep 2015 | - | $340.87M(+2.1%) | $1.31B(+2.7%) |
| Jun 2015 | - | $333.75M(+7.9%) | $1.28B(+3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $309.30M(-5.7%) | $1.24B(+5.3%) |
| Dec 2014 | $1.17B(+34.4%) | $328.14M(+7.0%) | $1.17B(+8.5%) |
| Sep 2014 | - | $306.58M(+5.3%) | $1.08B(+7.4%) |
| Jun 2014 | - | $291.23M(+17.9%) | $1.01B(+9.0%) |
| Mar 2014 | - | $246.92M(+4.7%) | $923.11M(+5.8%) |
| Dec 2013 | $872.42M(+48.9%) | $235.77M(+1.6%) | $872.42M(+6.3%) |
| Sep 2013 | - | $232.16M(+11.5%) | $820.35M(+7.4%) |
| Jun 2013 | - | $208.25M(+6.1%) | $763.71M(+12.4%) |
| Mar 2013 | - | $196.24M(+6.8%) | $679.69M(+16.0%) |
| Dec 2012 | $585.98M(+115.2%) | $183.70M(+4.7%) | $585.98M(+20.6%) |
| Sep 2012 | - | $175.51M(+41.3%) | $485.81M(+26.6%) |
| Jun 2012 | - | $124.23M(+21.2%) | $383.59M(+18.4%) |
| Mar 2012 | - | $102.53M(+22.7%) | $323.93M(+19.0%) |
| Dec 2011 | $272.28M(+56.7%) | $83.54M(+14.0%) | $272.28M(+12.5%) |
| Sep 2011 | - | $73.29M(+13.5%) | $242.11M(+13.4%) |
| Jun 2011 | - | $64.57M(+26.9%) | $213.57M(+12.7%) |
| Mar 2011 | - | $50.88M(-4.7%) | $189.49M(+9.0%) |
| Dec 2010 | $173.78M(+35.3%) | $53.37M(+19.3%) | $173.78M(+9.5%) |
| Sep 2010 | - | $44.75M(+10.5%) | $158.70M(+9.6%) |
| Jun 2010 | - | $40.49M(+15.1%) | $144.75M(+2.3%) |
| Mar 2010 | - | $35.17M(-8.1%) | $141.55M(+10.2%) |
| Dec 2009 | $128.45M(+90.3%) | $38.28M(+24.3%) | $128.45M(+17.0%) |
| Sep 2009 | - | $30.81M(-17.4%) | $109.76M(+13.5%) |
| Jun 2009 | - | $37.28M(+68.9%) | $96.70M(+29.0%) |
| Mar 2009 | - | $22.08M(+12.7%) | $74.96M(+11.0%) |
| Dec 2008 | $67.51M(+3.4%) | $19.59M(+10.4%) | $67.51M(+6.5%) |
| Sep 2008 | - | $17.75M(+14.2%) | $63.40M(-5.6%) |
| Jun 2008 | - | $15.54M(+6.2%) | $67.12M(+1.9%) |
| Mar 2008 | - | $14.63M(-5.4%) | $65.85M(+0.8%) |
| Dec 2007 | $65.30M(+45.6%) | $15.48M(-27.9%) | $65.30M(+6.2%) |
| Sep 2007 | - | $21.47M(+50.5%) | $61.50M(+19.0%) |
| Jun 2007 | - | $14.26M(+1.2%) | $51.70M(+5.3%) |
| Mar 2007 | - | $14.09M(+20.7%) | $49.11M(+9.5%) |
| Dec 2006 | $44.86M(+109.2%) | $11.67M(0.0%) | $44.86M(+16.4%) |
| Sep 2006 | - | $11.67M(0.0%) | $38.54M(+19.6%) |
| Jun 2006 | - | $11.67M(+18.7%) | $32.23M(+24.4%) |
| Mar 2006 | - | $9.84M(+83.5%) | $25.92M(+20.9%) |
| Dec 2005 | $21.44M | $5.36M(-0.0%) | $21.44M(+33.3%) |
| Sep 2005 | - | $5.36M(0.0%) | $16.08M(+50.0%) |
| Jun 2005 | - | $5.36M(0.0%) | $10.72M(+100.0%) |
| Mar 2005 | - | $5.36M | $5.36M |
FAQ
- What is Jazz Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual revenue year-on-year change?
- What is Jazz Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly revenue year-on-year change?
- What is Jazz Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals TTM revenue year-on-year change?
What is Jazz Pharmaceuticals annual revenue?
The current annual revenue of JAZZ is $4.07B
What is the all time high annual revenue for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual revenue is $4.07B
What is Jazz Pharmaceuticals annual revenue year-on-year change?
Over the past year, JAZZ annual revenue has changed by +$234.75M (+6.12%)
What is Jazz Pharmaceuticals quarterly revenue?
The current quarterly revenue of JAZZ is $897.84M
What is the all time high quarterly revenue for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly revenue is $1.09B
What is Jazz Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, JAZZ quarterly revenue has changed by -$4.14M (-0.46%)
What is Jazz Pharmaceuticals TTM revenue?
The current TTM revenue of JAZZ is $4.06B
What is the all time high TTM revenue for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high TTM revenue is $4.07B
What is Jazz Pharmaceuticals TTM revenue year-on-year change?
Over the past year, JAZZ TTM revenue has changed by +$221.43M (+5.76%)